Contact us for information regarding our sample policy
As per Order
Western Europe North America Eastern Europe Middle East Central America Africa South America Asia Australia
WHO GMP
Product Description
Emtricitabine is approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults, children, and infants. Emtricitabine is always used in combination with other anti-HIV medicines. Emtricitabine can also be used off-label to treat opportunistic infections of HIV infection.